West Pharmaceutical Services Inc
- Stock
- Ticker WST
- ISIN US9553061055
- NYSE
Performance, volatility and drawdowns of West Pharmaceutical Services Inc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $50,380. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −59.3% in 04/2025, measured from the peak in 12/2021. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 749 | 698 | 767 | 805 | 805 | 845 | 872 | 875 |
| Gross profit | 274 | 232 | 274 | 294 | 304 | 296 | 329 | 347 |
| Operating income | 160 | 107 | 154 | 168 | 157 | 177 | 179 | 267 |
| EBITDA | 200 | 147 | 195 | 211 | 204 | 222 | 225 | 313 |
| Net income | 130 | 90 | 132 | 140 | 132 | 139 | 154 | 214 |
| Earnings per share | 1.78 | 1.23 | 1.82 | 1.92 | 1.82 | 1.92 | 2.15 | 3.02 |
| Balance sheet | ||||||||
| Total assets | 3,643 | 3,618 | 3,953 | 4,106 | 4,270 | 4,110 | 4,076 | 4,061 |
| Liabilities | 961 | 935 | 1,024 | 1,054 | 1,094 | 1,119 | 1,086 | 1,093 |
| Equity | 2,682 | 2,683 | 2,929 | 3,052 | 3,176 | 2,990 | 2,990 | 2,968 |
| Cash | 485 | 404 | 510 | 629 | 791 | 521 | 436 | 464 |
| Long-term debt | 203 | 203 | 203 | 203 | 203 | 203 | 203 | 203 |
| Cash flow | ||||||||
| Operating cash flow | 190 | 129 | 177 | 197 | 251 | 90 | 124 | 190 |
| Capital expenditure | -105 | -71 | -75 | -63 | -76 | -43 | -43 | -39 |
| Free cash flow | 85 | 58 | 102 | 134 | 175 | 47 | 81 | 150 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2020 at +89.1%, weakest 2022 at −49.7%. 5 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 29 Oct 2026 | $3.02 |
| 23 Jul 2026 | $2.15 |
| 23 Apr 2026 | $1.92 |
| 17 Feb 2026 | $1.82 |
| 23 Oct 2025 | $1.92 |
| 24 Jul 2025 | $1.82 |
| 24 Apr 2025 | $1.23 |
| 18 Feb 2025 | $1.78 |
| 24 Oct 2024 | $1.85 |
| 25 Jul 2024 | $1.51 |
| 25 Apr 2024 | $1.55 |
| 20 Feb 2024 | $1.83 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €25bn
- Market cap in trading currency
- $27.2bn
- Enterprise value
- $26.9bn
- P/E
- 43.8
- P/S
- 8.00
- P/B
- 9.16
- EV/Sales
- 7.93
- EV/EBITDA
- 27.9
- Earnings yield
- 2.3%
- FCF yield
- 1.7%
Results (last four quarters)
- Revenue
- $3.40bn
- Gross profit
- $1.28bn
- EBITDA
- $965m
- Net income
- $639m
- Earnings per share
- $8.91
- Revenue per share
- $48.76
- Revenue growth
- +8.7%
- Earnings growth
- +52.9%
Profitability
- Gross margin
- 37.6%
- Operating margin
- 23.0%
- Net margin
- 18.8%
- Return on equity
- 21.2%
- Return on assets
- 15.7%
Balance sheet and cash flow
- Cash
- $464m
- Cash per share
- $6.66
- Financial debt
- $203m
- Debt/equity %
- 7
- Current ratio
- 2.82
- Book value per share
- $42.61
- Operating cash flow
- $655m
- Free cash flow
- $453m
Dividend
- Dividend yield
- 0.30%
- Dividend (12 months)
- $1.18
- Yield (12 months)
- 0.30%
- Payout ratio
- 13%
- Ex-dividend date
- 11 Nov 2026
Shares and trading
- Shares outstanding
- 69.7m
- Volume
- 595,074
- Avg. volume 3 months
- 610,443
- Relative volume
- 1.0
Price and technicals
- Price
- $390.30
- 1 day
- −1.6%
- 52-week high
- $417.80
- 52-week low
- $230.95
- Distance to 52-week high
- −6.6%
- Distance to 52-week low
- +69.0%
- Distance to 50-day line
- +1.0%
- Distance to 200-day line
- +19.8%
- RSI (14)
- 43
- Volatility 1M
- 27.8%
Performance
- 1 week
- −6.3%
- 1 month
- −0.9%
- 3 months
- +10.5%
- 6 months
- +23.3%
- YTD
- +41.9%
- 1 year
- +51.3%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has WST performed since 11/2016?
$10,000 grew to $50,380 by 20 Nov 2026, which is +17.6% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is WST?
Volatility was 30.6% per year, measured on monthly returns. The largest decline from a peak was −59.3%, with the low in 04/2025.
How does WST compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, WST returned +17.6% at 30.6%. The correlation of monthly returns was 0.48; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.